
Düsseldorf, Germany – November 16, 2026 – Microprofit Biotech, a leading innovator in the In Vitro Diagnostics (IVD) industry, is proud to announce its participation in MEDICA 2026, the world’s premier medical trade fair. We cordially invite global distributors, healthcare providers, and industry partners to visit us at the Düsseldorf Exhibition Centre from November 16th to 19th.
This year, the highlight of our presence will be the unveiling of our latest diagnostic innovations under the fluorecare® brand. Our team has been dedicated to pushing the boundaries of medical technology, and we are excited to showcase our newly developed platforms designed to enhance clinical efficiency and patient care.
Visitors to our booth will have the opportunity to explore:
Advanced POCT Solutions: Next-gen platforms for quantitative analysis with high precision.
Innovative Multiplex Testing: New rapid diagnostic kits for comprehensive disease screening.
Strategic Partnership Opportunities: Tailored support models for global distribution and market expansion.
As a "Specialized, Refined, Differential and Innovative" (SRDI) enterprise, Microprofit Biotech continues to lead in the decentralization of healthcare. Our fluorecare® ecosystem—ranging from high-sensitivity respiratory combo tests to professional cardiac marker platforms—is engineered to meet the evolving needs of modern clinics and laboratories worldwide.
Event Name: MEDICA 2026
Date: November 16 – 19, 2026
Location: Düsseldorf Exhibition Centre, Germany
Microprofit Booth: Hall 3, Booth 3A16
We look forward to discussing how our cutting-edge diagnostic tools can add value to your business or clinical practice. To ensure a dedicated time slot with our international sales team, we encourage you to [Book a Meeting] in advance via our official website.
Microprofit Biotech & fluorecare® — Innovation for a Healthier World.